dystrophic epidermolysis bullosa (DEB) treatment market

added blog Film

2025-07-08 15:57:16 -

IntroductionThe dystrophic epidermolysis bullosa (DEB) treatment market is witnessing notable growth driven by rising awareness, advancements in gene therapy, and increasing clinical trials focused on rare skin disorders. DEB is a severe and rare genetic skin condition characterized by fragile skin that blisters easily. The demand for targeted therapies and supportive care solutions is...

0 Comments 0 Shares 124 Views 0 Reviews